NCT05716750 is a NA clinical trial of Vitamin D in Osteomalacia, sponsored by TUĞBA ŞAHBAZ.

Who is sponsoring NCT05716750?

NCT05716750 is sponsored by TUĞBA ŞAHBAZ.

What drugs are being tested in NCT05716750?

Interventions in NCT05716750: Vitamin D.

What condition does NCT05716750 study?

NCT05716750 studies Osteomalacia.

Is NCT05716750 still recruiting?

NCT05716750 is currently status unknown. Last updated 14 February 2023.

Last reviewed 2023-02-14 · How we verify

NCT05716750

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Serum Prolidase Activity and the Role of Leptin in Osteomalacia

Status unknown NA Last updated 14 February 2023

What this trial tests

NA trial testing Vitamin D in Osteomalacia in 38 participants. Status unknown.

Timeline

15 February 2023

Primary endpoint
30 April 2023

30 June 2023

Quick facts

Lead sponsor	TUĞBA ŞAHBAZ
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	38
Start date	15 February 2023
Primary completion	30 April 2023
Estimated completion	30 June 2023

Drugs / interventions tested

Vitamin D

Conditions studied

Osteomalacia — all drugs for Osteomalacia →

Sponsor

TUĞBA ŞAHBAZ

Who can join

Adults 18 to 65, any sex, with Osteomalacia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluation of the change of serum Prolidase and Leptin values in the diagnosis and follow-up of osteomalacia and its clinical usability

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Vitamin D

Trials testing the same drug.

NCT07366086 — Pediatric Safety Follow-up Study of Prior Treatment With Romosozumab for Osteogenesis Imperfecta · Phase 3 · recruiting
NCT07458815 — Vitamin D for Acute Intracerebral Hemorrhage · NA · not yet recruiting
NCT07491965 — Association Between Benign Paroxysmal Positional Vertigo and Vitamin D Deficiency . · not yet recruiting
NCT07400757 — Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease · NA · not yet recruiting
NCT07293910 — Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Py · Phase 2 · recruiting

Other recruiting trials for Osteomalacia

Currently open trials in the same condition.

NCT00024804 — A Natural History Study of Bone and Mineral Disorders · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05716750 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by TUĞBA ŞAHBAZ
Last refreshed: 14 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05716750.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing